Medical News

RSS

Researchers identify a signature of three genes linked to positive response to blood cancer therapy

Mount Sinai researchers have for the first time identified genes that predict a good response to a vital new therapy for a blood cancer that can have serious side effects for some patients.

16 Jun 2022

Chemical synthesis, properties, and molecular modeling studies of spiro-indole compounds

In a recent study under review at the Scientific Reports journal and currently posted to the Research Square* preprint server, researchers synthesized and evaluated the antitumoral (against several cancer cell lines) and antiviral [against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] properties of 3-spiro-indolin-2-ones.

15 Jun 2022

Evidence COVID in pregnancy can affect offspring's neurodevelopment

In a recent study published in the Jama Network Open journal, researchers investigated the impact of in utero exposure to coronavirus disease 2019 (COVID-19) on the neurodevelopment of infants.

15 Jun 2022

Countries with female leaders recorded fewer COVID-19 deaths, study finds

Countries with female leaders recorded 40 per cent fewer COVID-19 deaths than nations governed by men, according to University of Queensland research.

15 Jun 2022

UQ researchers call for an urgent review of low vaccination rates during pregnancy

University of Queensland researchers are calling for an urgent review of low influenza vaccination rates for pregnant women and whooping cough vaccinations for young and Aboriginal and/or Torres Strait Islander mothers-to-be.

15 Jun 2022

Stanford researcher outlines pollution and climate change threats to children's health

Horror stories of children trapped in hot cars make headlines, but air pollution and impacts from a changing climate are more constant threats.

15 Jun 2022

Dog-assisted interventions can lead to lower stress in children

Dog-assisted interventions can lead to significantly lower stress in children both with and without special needs, according to a new study using salivary cortisol levels published this week in the open-access journal PLOS ONE by Kerstin Meints of University of Lincoln, UK, and colleagues.

15 Jun 2022

New thulium fiber laser system may provide improved outcomes in pediatric patients with urinary stones

A new thulium fiber laser system may provide improved outcomes in the treatment of urinary stones for pediatric patients, compared to the current standard for laser lithotripsy, reports a study in The Journal of Urology, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

15 Jun 2022

Scientists estimate the incubation period of 2022 monkeypox

In a recent study posted to the medRxiv* preprint server, researchers in the Netherlands estimated the incubation period for monkeypox.

15 Jun 2022

Annual Wellness Visits associated with reduced risk of amputations in patients with diabetes

Patients with diabetes who participate in a free Annual Wellness Visit covered by Medicare are 36% less likely to need an amputation, a new study from University of Virginia School of Medicine researchers and their collaborators found.

15 Jun 2022

Loss of a grandmother may have repercussions for the loved ones she leaves behind

Losing a beloved family member is never easy, but a new study suggests the loss of a grandmother in particular may have repercussions for the loved ones she leaves behind.

15 Jun 2022

Fc-effector functions for selecting COVID-19 convalescent plasma

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment crystallizable (Fc)-effector activity result in effective prophylaxis.

15 Jun 2022

People with mental health problems at higher risk for severe COVID-19 outcomes

In a recent study published in the CDC’s Emerging Infectious Diseases journal, researchers assessed the associations between mental health conditions (MHCs) and severe outcomes of coronavirus disease 2019 (COVID-19).

15 Jun 2022

LifeArc and UK DRI launch new partnership to accelerate development of new treatments for dementia

LifeArc and the UK Dementia Research Institute (UK DRI) have today launched a new partnership to accelerate development of new diagnostic tests, treatments, and devices from scientific research discoveries to benefit people with dementia, which around 900,000 people in the UK are living with.

15 Jun 2022

Two broadly neutralizing antibodies show promise to provide long-acting immunity against SARS-CoV-2

Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a paper published June 15 in the Journal of Experimental Medicine (JEM).

15 Jun 2022

Researchers create first bona fide mouse model of Merkel cell carcinoma

A team of researchers at the University of Michigan Rogel Cancer Center were the first to generate a bona fide mouse model of a Merkel cell carcinoma, a rare and potentially aggressive form of skin cancer.

15 Jun 2022

More than £15 million funding will help local authorities to implement new social care charging reforms

More than £15 million will be given to local authorities across England today (Wednesday 15 June) to help them implement new social care charging reforms to bring an end to the unpredictable cost of care for the public.

15 Jun 2022

SARS-CoV-2 damages cilia

Researchers determine whether the interaction between ORF10 and ZYG11B promotes the dissemination of SARS-CoV-2.

15 Jun 2022

Drug combinations may help to slow the progression of diabetic kidney disease

A mouse study led by Washington University School of Medicine in St. Louis suggests that combining SGLT2 inhibitors — a newer class of diabetes medications that lowers blood sugar — with older diabetes drugs may help to slow the progression of diabetic kidney disease.

15 Jun 2022

Treating anal precancerous growths reduces risk of anal cancer by more than half in HIV patients

A large clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions, or HSIL, reduces the chance that anal cancer will develop by more than half.

15 Jun 2022

Medical News

Researchers identify a signature of three genes linked to positive response to blood cancer therapy

Chemical synthesis, properties, and molecular modeling studies of spiro-indole compounds

Evidence COVID in pregnancy can affect offspring's neurodevelopment

Countries with female leaders recorded fewer COVID-19 deaths, study finds

UQ researchers call for an urgent review of low vaccination rates during pregnancy

Stanford researcher outlines pollution and climate change threats to children's health

Dog-assisted interventions can lead to lower stress in children

New thulium fiber laser system may provide improved outcomes in pediatric patients with urinary stones

Scientists estimate the incubation period of 2022 monkeypox

Annual Wellness Visits associated with reduced risk of amputations in patients with diabetes

Loss of a grandmother may have repercussions for the loved ones she leaves behind

Fc-effector functions for selecting COVID-19 convalescent plasma

People with mental health problems at higher risk for severe COVID-19 outcomes

LifeArc and UK DRI launch new partnership to accelerate development of new treatments for dementia

Two broadly neutralizing antibodies show promise to provide long-acting immunity against SARS-CoV-2

Researchers create first bona fide mouse model of Merkel cell carcinoma

More than £15 million funding will help local authorities to implement new social care charging reforms

SARS-CoV-2 damages cilia

Drug combinations may help to slow the progression of diabetic kidney disease

Treating anal precancerous growths reduces risk of anal cancer by more than half in HIV patients

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News